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Abstract
Background: Functional analysis of data from genome-scale experiments, such as microarrays,
requires an extensive selection of differentially expressed genes. Under many conditions, the
proportion of differentially expressed genes is considerable, making the selection criteria a balance
between the inclusion of false positives and the exclusion of false negatives.
Results: We developed an analytical method to determine a p-value threshold from a microarray
experiment that is dependent on the quality and design of the data set. To this aim, populations of
p-values are modeled as mathematical functions in which the parameters to describe these
functions are estimated in an unsupervised manner. The strength of the method is exemplified by
its application to a published gene expression data set of sporadic and familial breast tumors with
BRCA1 or BRCA2 mutations.
Conclusion: We present an objective and unsupervised way to set thresholds adapted to the
quality and design of the experiment. The resulting mathematical description of the data sets of
genome-scale experiments enables a probabilistic approach in systems biology.
Background
Functional analysis of microarray data, e.g. to reveal
enrichment of promoter sequences, metabolic pathways
or signalling cascades, requires an extensive selection of
differentially expressed genes. Arbitrarily chosen thresh-
olds for fold-changes and/or significance of change are
commonly used to split the genes in subsets of alternative
(differentially expressed) and null (non-differentially
expressed) genes, with acceptable proportions of false
positives and false negatives. Which proportion is accept-
able depends on the research question. For example, to
find markers of a treatment or signatures of a mutation, it
is usually enough to fix the FDR-control level [1], and
select the most significant alternative genes. However,
most differentially expressed genes will not be selected.
For other purposes, e.g. when comparing differences
between treatments or mutations, there is need for more
thorough comparisons. For each gene we would like to
know the probability of it being alternative or null. Such
an approach will let us select genes that are truly – or truly
not – differentially expressed, with associated estimates of
false positives.
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The differential expression of genes is evaluated after a
comparison of gene expression levels, yielding a list of p-
values. Commonly, a threshold is then fixed for either the
number of genes selected, or for their p-value, and those
genes corresponding to the k smallest p-values are classi-
fied as alternative. However, because of the large number
of p-values involved, even if all features are null some
small p-values may be observed due to pure chance. Thus,
it is important to consider an estimate for the proportion
of alternative features while determining the threshold.
The problem of estimating the proportion of alternative
and null features has been handled by several authors [2-
5]. In many experimental settings the alternative features
make up a considerable fraction. This is a consequence of
genes being connected in networks; altered expression of
one gene can affect expression levels of multiple targets.
Begley and co-workers [6] showed that the methylating
agent MMS induced changes in the transcription level of
33% of the genes in the S. cerevisiae genome and oxidizing
agent t-BuOOH altered 38% of the genes. In a study of
familial and sporadic human breast cancers by Hedenfalk
and co-workers [7], Storey and Tibshirani [5] estimated
33% of the genes to be differentially expressed between
BRCA1 and BRCA2 mutation positive tumors. However,
even though over 1,000 genes were considered to be
changed, only 160 genes could be selected with a pFDR of
5% as a consequence of the overlap between alternative
and null genes. It is intuitive that using only 16% of the
differentially expressed genes for functional analysis is
suboptimal, and we will show that this is indeed the case.
To detect subtle but coordinated changes in gene expres-
sions, it is advantageous to examine the joint behavior of
inter-connected sets of genes [8], which implies the need
for a generous selection. Significant changes in cellular
processes can be detected in cases where the alteration of
individual gene expressions is not significant [9].
The threshold determination has so far been left to the
researcher. In practice it is either guided by limitations in
the number of features to be verified after being classified
as alternative, or by the desired false positive proportion
in the final list. However, with the increasing rate at which
new experiments are being performed, and decreasing
cost of verification experiments, there will be a growing
need for unsupervised ways of determining thresholds
yielding a list of features with acceptable false positive and
false negative rates.
We present here an objective and unsupervised way to set
thresholds that are adapted to the quality and design of
the experiment. Description of the distribution of both
null and alternative p-values as mathematical functions
will give the researcher the possibility to select genes
depending on the probability of being alternative or null.
Result
A case study
Hedenfalk et al [7] determined gene expression patterns
in 21 tumors from breast cancer patients. Seven tumors
were sporadic with unknown mutations, whereas the
remainder were familial cancers, in which one of the
known genes associated with breast cancer was mutated:
BRCA1 (7 patients) or BRCA2 (8 patients). RNAs from the
three different sources were hybridized to arrays contain-
ing 6,512 cDNA clones. After discarding low quality spots
[5,7], more than 3,000 clones remained. The measure-
ments from these genes were tested against the null
hypothesis that there is no differential expression across
two conditions [5]. The resulting p-values can be visual-
ized in density histograms (figure 1A,C and supplemen-
tary material). The p-values appear to follow the expected
distribution as being composed of a population of truly
null (non-differentially expressed) genes with p-values
uniformly distributed among [0, 1] and a population of
truly alternative (differentially expressed) genes with p-
values that tend to be close to zero. Similar shapes of dis-
tributions can be generated for all four tested compari-
sons, BRCA1 to sporadic, BRCA2 to sporadic, BRCA1 to
BRCA2 and both BRCA1 and BRCA2 to sporadic.
Decomposing distributions and setting thresholds
To further examine the gene expression responses, we
describe the alternative and null distributions as mathe-
matical functions. For this purpose, we plot the genes
sorted by their p-values, p, against the percentile ranks
(rank position/the total number of p-values), y (figure 1B)
to reveal F-1, the inverse of the underlying cumulative den-
sity function. F-1 is estimated non-parametrically. When
comparing BRCA1 mutation-positive tumors against spo-
radic tumors,   is convex upward on the entire interval
y = [0, 1]. The curvature   (dotted line in fig-
ure 1B) has a major peak (at y0 = 0.30 corresponding to p0
= 0.19) indicating that there is one dominating popula-
tion of alternative genes. The expression for f(p0) gives us
a rough   estimated to 0.77. Other methods specifically
designed to estimate   yielded similar results; Storey
and Tibshirani's method [5] led to   = 0.83 and the
method developed by Schweder and Spjotvoll [4] resulted
in   = 0.82. Under the assumption that the p-values of
the alternative genes follow an exponential distribution,
we calculate   to 8.3 (see methods section). With the
parameters   and   we can describe the null and alter-
native density functions (dashed lines in figure 1A). To
select differentially expressed genes, we use the critical
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Distributions of p-values from the Hedenfalk data set Figure 1
Distributions of p-values from the Hedenfalk data set. (A,C) Density histograms for the more than 3,000 genes com-
paring (A) BRCA1-mutated and sporadic tumors or (C) BRCA1- and BRCA2-mutated tumors. The dashed lines show the esti-
mated distributions of the alternative (curves) and null (horizontal lines) genes, and solid lines show the sum the estimated 
distributions. (B,D) Scatterplots where the p-value of each gene is plotted against the percentile rank. A smooth function is fit-
ted (solid line) and the local maxima of the curvature (dashed line) are used to split the null and alternative populations of 
genes for the comparisons (B) BRCA1-mutated and sporadic tumors or (D) BRCA1- and BRCA2-mutated tumors.BMC Bioinformatics 2005, 6:177 http://www.biomedcentral.com/1471-2105/6/177
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point  p0  as a p-value threshold. As a result, the null
hypothesis was accepted for 2,083 genes with a p > 0.19.
These genes all have at least a twice larger probability of
being null than alternative. In general, since we have a
mathematical description of f(p) any point can be chosen
as threshold. For instance, we can calculate a point, p1,
where genes have at least a two times larger probability of
being alternative than null. Hundred-and-eighty genes
have a p-value below this threshold of p1 = 0.04, and are
selected as alternative. The proportion of false positives, as
estimated by the ratio of integrals of f0 and f in the interval
[0, p1], amounts to 20%. The pFDR estimated by Storey
and Tibshirani [5] is 34%. Notably, in this comparison at
a pFDR of 5%, being the proposed threshold by Storey
and Tibshirani [5], no gene is selected as being differen-
tially expressed.
Comparing expression data from BRCA2  and sporadic
tumors shows similar patterns (  = 0.75 and   = 11.1)
(supplementary figure 1). Here, using p0 as the p-value
threshold 2,168 genes are selected as being null. Only
20% of the genes with p <p0(BRCA1) or p <p0(BRCA2) are in
common in both comparisons, suggesting that BRCA1
and BRCA2 affect different target genes.
Information on the genes affected in both BRCA1 and
BRCA2  mutation-positive tumors can be obtained by
comparing the data from the familial tumors together
against the sporadic. The curvature of  , revealing the
genes in common between BRCA1 and BRCA2 mutated
tumors, has two local maxima (supplementary figure 1).
Also when the data from BRCA1 is compared to that from
BRCA2 mutated tumors (figure 1C–D), the curvature plot
has several local maxima. These observations indicate that
the original distributions might be constituted of p-values
from two or more populations of truly alternative genes in
addition to the truly null genes. Each of these groups is
represented by a close to linear part in the plot of  .
The critical points of the curvature of   and the cor-
responding  p-values let us estimate the parameters to
describe the distributions of the groups.
Simulation study
In order to verify how the method works in a case for
which the result is known, a simulation study was per-
formed. It was assumed for simplicity that each alternative
p-value followed an exponential distribution with rate λ.
For values of λ between 1 and 100, and varying propor-
tions  π0 of alternative p-values within [0, 1], a set of
10,000 independent p-values was generated. For each of
these sets, an estimate   was computed for π0 using the
method developed by Storey and Tibshirani [5]. Subse-
quently, an estimate   for λ was determined via a non-
parametric approach (see methods section). A graph of
the estimate   for all combinations of λ and π0 values, is
shown in figure 2. The relative error in   was determined
as   and the proportion of false positives and false
negatives were calculated by   and
 respectively.
The results show that   gives a reasonable estimate of λ
for 0.20 <π0 < 0.95 and λ > 5 (figure 2). The proportion of
false positives obtained for these values is 0.03 ± 0.01
(mean ± s.d.), and the proportion of false negatives is 0.04
± 0.03. When few alternative features are present (π0 =
0.95), λ cannot be determined. Also when the alternative
distribution is close to uniform (λ < 5),   fails to correctly
estimate  λ. For π0 = 0.20, λ  is over-estimated and the
method yields a conservative threshold, meaning that the
proportion of false positives is low on the expense of a
high proportion of false negatives. However, π0 being ≤
0.20 is of relatively little practical interest, as typically by
design, studies already contain a large fraction of
unchanged genes.
We also compared the proportions of false positives and
false negatives between different methods for selecting
genes, e.g. while controlling the family wise error-rate
(FWER) or the FDR (figure 3). The proportion of false calls
largely depends on the separation between alternative and
null features (the value of λ) for thresholds based directly
on the p-values. As to be expected, when correcting for
multiple testing, i.e. controlling the FWER or FDR, the
proportion of false positives remains constant.
Similar calculations can be made for complex populations
with more than one population of alternative features.
Functional analysis
To discern alternated cellular processes, we performed an
analysis at gene set level [8,9]. To obtain a description of
the function of the affected genes (p <p0) in the BRCA
study, the genes on the arrays were associated with Gene
Ontology (GO) terms [10]. The annotation of the genes in
the original data files were updated to the Unigene 170
build (24 April 2004). Of the informative transcripts on
the array, 62% could be attributed to gene sets that repre-
sent specific GO terms. Subsequently, the hypergeometric
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Calculation of p0 and estimations of λ from a simulation study Figure 2
Calculation of p0 and estimations of λ from a simulation study. 10,000 p-values were simulated in a mixture of an 
alternative and a null distribution. As functions of λ ∈ [1, 100] and π0 ∈ [0, 1] are shown: (A) ,  (B) the relative error in 
, (C) the proportion of false positives (PFP) and (D) false negatives (PFN) when selecting the genes with p <p0. 
NB the inverse arrow of π0 in (C).
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probability of the genes in each gene set being randomly
distributed around the threshold, p0, was calculated.
where x is the number of affected genes in the gene set, N
is the total number of affected genes, n is the total number
of genes in the gene set and m is the total number of genes
not in the gene set. In cases of several p0, we chose p0 cor-
responding to the major peak of the curvature plot, or if
two major peaks are close to each other, the one associ-
ated with the largest p0.
The significant gene sets and the affected genes in the four
comparisons are shown in supplementary tables 1–4.
When comparing BRCA2 and sporadic, only three gene
sets were significantly (p < 0.01) altered, one consisting of
genes involved in DNA repair. For BRCA1, 15 genes sets
are significantly (p < 0.01) altered. The genes involve DNA
binding, phosphorylation and cell cycle. Among the six
enriched gene sets in the comparison between familial
(BRCA1 and BRCA2) and sporadic tumors, the most sig-
nificant enrichment is that of genes associated with the
mitochondria. Almost as significant is the lack of electron
transport genes among the selected genes.
We then tried to select genes using alternative methods.
When controlling the FWER or the Benjamini-Yuketieli
FDR, no genes were selected at the level α = 0.05 and
when using the Benjamini-Hochberg FDR only the com-
parison between BRCA1 and BRCA2 yielded a non-zero
list of genes. At the control-level α = 0.2, all four compar-
isons resulted in lists comprised of 2–450 genes, which is
much less (familial versus sporadic) or comparable
Comparisons between p0 and other selection methods in a simulation study Figure 3
Comparisons between p0 and other selection methods in a simulation study. 10,000 p-values were simulated in a 
mixture of an alternative and a null distribution. The proportions of false positives (A) and false negatives (B) are depicted as 
functions of λ ∈ [1, 100], π0 is set at 0.67. Selecting the genes with p <p0 (black) is compared to: selecting the genes with p < 
0.001 (brown) or p < 0.1 (red); controlling the Benjamini-Hochberg FDR at α = 0.05 (dark blue) or α = 0.2 (light blue); the 
Benjamini-Yekutieli FDR at α = 0.2 (dark green) and the FWER at α = 0.2 (light green). The lines represent means of twenty 
simulations.
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(BRCA1 versus BRCA2) to the number of genes selected as
having p <p0. The significant genes sets after gene set anal-
ysis are partially overlapping with the results from the p0
threshold (supplementary tables 5–8).
For visualization of the distributions, we used a modified
version of 'gene set enrichment analysis' [8], where the
genes were sorted on the p-values to form a sequence.
Genes belonging to the tested gene set are attributed a
value of   and the remaining genes are given the value
. The cumulative sum of the sequence is calculated
and plotted for a few gene sets in figure 4. The more a gene
set deviates from a uniform distribution, the greater abso-
lute value of the sum. For these gene sets, the threshold at
p0 coincides with the maximum of the cumulative sum.
Discussion
High-throughput techniques such as gene expression pro-
filing by microarrays allows rapid screening of large
amounts of data simultaneously. However, the staggering
amount of data produced causes new problems, such as
how to determine a meaningful p-value threshold
between differentially expressed and unchanged genes.
Methods such as Benjamini & Hochberg's [1] or Ben-
jamini & Yekutieli's [11] control false positives propor-
tions, but yield no information about false negatives
proportions. Our method can produce a full description
of the probability density function for differentially
expressed genes, which makes it possible to rationally
choose a desired ratio between π0 and 1 - π0 for which the
p-value threshold can be calculated.
The most important features of our proposed p-value
threshold are that it is data dependent and unsupervised.
It relies on an independent estimate of the unchanged
genes proportion,  . The method works best for π0 ∈
(0.20,0.95) and λ > 5, situations in which the number of
alternative features is non-negligible and has a minimum
separation from the null features.
The value of λ will increase with the separation of the pop-
ulations of alternative and null genes. The power of the
statistical test will also be reflected on λ, as well as the
quality of the data. On commercial platforms with multi-
ple synthetic probes, λ tends to be higher than on micro-
arrays spotted with PCR products (data not shown).
As the tolerable amount of false calls depends on the
research question, relaxed selection criteria are needed for
questions which require a balance between the inclusion
of false positives and the exclusion of false negatives. Con-
ventional ways of selecting genes, such as stringent con-
trol of the FWER or FDR, select few, if any, false positives
whereas the proportion of false negatives is at its maxi-
mum even with good separation between alternative and
null features (figure 3). Only when relaxing the thresholds
are we able to bring the two rates into equilibrium. Ide-
ally, with no overlapping populations between truly alter-
native and truly null genes and a single population of
alternative genes, the threshold at p0 will select   of
the total genes as differentially expressed. However, in
practice there is always some overlap in p-values between
truly alternative and truly null genes. Selection of genes
with p <p0 will frequently include many genes which can
be useful under some circumstances. For instance,
although in the examples of the case study the FDRs are
high at p0, almost all alternative genes are included, as can
be estimated by  . In the functional analysis,
the plots of the cumulative sums show that setting the
threshold at p0 is biologically valid. Up until these points
there is still a contribution of genes in the relevant gene
sets. A more stringent selection would neglect the evi-
dence of many genes being marginally differentially
expressed. By selecting genes through controlling the FDR,
similar results can be obtained with relaxed thresholds.
The analysis of biological function that we present on the
BRCA data set was expected to reveal groups of genes
related to the cellular processes that are affected by either
mutant BRCA1 or mutant BRCA2. Indeed for certain pre-
defined gene sets, e.g. genes involved in DNA repair, cell
cycle progression or nucleic acid interactions, the propor-
tion of genes with p <p0 is higher than can be expected
from a random distribution. The observation that the
threshold p0 coincides with the maximum of deviation
from zero in figure 4 suggests that p0 is at the breakpoint
where the enrichment of the gene set culminates. We
noticed that there are more gene sets significantly affected
by mutated BRCA1 than mutated BRCA2. Next to "protein
phosphorylation", specifically gene sets involved in cell
cycle regulation are enriched, including "cell cycle", and
the somewhat less significantly induced gene sets "mito-
sis" and "spindle". As for mutated BRCA2, there is no indi-
cation that its impairment affects cell cycle progression;
the genes in the gene set "mitosis" appear even to be
depleted among the affected genes. The involvement of
DNA repair is additionally endorsed by the less signifi-
cantly induced gene sets "response to stress" and "induc-
tion of apoptosis by extracellular signals". From the
literature we know that the BRCA network deals with
lesions that block or interfere with DNA replication.
BRCA1 has a role in DNA damage sensing but its precise
function is not known (for review see [12]). BRCA2 is
directly involved in DNA repair [13]. Interestingly, when
BRCA1 and BRCA2 mutation positive tumors are com-
m
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Enrichment of gene sets in the BRCA-study Figure 4
Enrichment of gene sets in the BRCA-study. Genes R1, ..., RN (N > 3,000) are ordered on their p-values and the cumula-
tive sum is calculated to determine whether the members of a gene set are enriched. Starting with the top-ranking gene, the 
sum increases when a gene in the gene set is encountered and decreases otherwise. The gene sets shown here are (A) cell 
cycle (solid line – BRCA1-sporadic; dashed line – BRCA2-sporadic) and (B) DNA repair (solid line – BRCA1-sporadic; dashed line 
– BRCA2-sporadic). (C) For the comparison BRCA1/2-sporadic, the gene sets consisting of genes functional in the mitochondria 
(solid line) and electron transport (dashed line) are depicted. The vertical dotted lines correspond to the thresholds, p0, for 
BRCA1, BRCA2 and BRCA1/2 compared to sporadic.BMC Bioinformatics 2005, 6:177 http://www.biomedcentral.com/1471-2105/6/177
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pared together against sporadic tumors, mitochondrial
genes are affected but not electron transport genes. Until
recently, the main function of mitochondria was thought
to be the provision of energy for the cell through the crea-
tion of an electrical potential across its membrane. How-
ever, mitochondria are also involved in one route of
apoptosis and recently there has been evidence for dys-
functional mitochondria being associated with premature
ageing [14]. These are functions that could possibly be
connected to the BRCA network.
Conclusion
The method presented here will allow researchers to set
unsupervised thresholds to select alternative features from
mixed populations of p-values. As the discipline of sys-
tems biology evolves, there will be a need to compare glo-
bal measurements of different levels (RNA, proteins,
metabolites, etc.). The evidence of features being alterna-
tive can be used as weights in a comparison. In this con-
text, a mathematical description of significant features
enables a probabilistic approach to identify affected
pathways.
Method
Setting thresholds
The p-values are defined as independent continuous ran-
dom variables P1, P2, ..., Pn taking values in the interval [0,
1]. Let us represent by f and F the probability density and
cumulative probability functions of the distribution of a
generic p-value P, respectively. We require that f is twice
differentiable.
We represent by f0(p) and f1(p) the p-value densities for a
null feature and an alternative feature, respectively. For a
generic feature, its p-value density can be written as the
mixture
f(p) = π0f0(p) + (1 - π0) f1(p), ∀ p ∈ [0, 1],   (1)
where π0 represents the proportion of null features out of
the total under study. Note that f0(p) takes the value 1 for
all p within [0, 1].
A common way of visualizing all p-values is to make a
graph of the sorted p-values according to the features (see
for example the solid line in figures 1B and 1D). If there
are no alternative features, this line should roughly be a
straight line with a 45 degrees angle. The presence of alter-
native features makes the line more convex, as seen in our
examples. This line corresponds to F-1, where F  is the
cumulative probability function as defined above.
We represent by p0 the p-value threshold defining the larg-
est p-value corresponding to features identified as alterna-
tive. We shall define p0 as the maximum of the second
derivative of F-1. The second derivative correspond to the
curvature of the original function. Using (1), we get that
p0 satisfies
Note that there need not be a unique value of p0 satisfying
(2). The derivation of the equation is given in the
appendix.
For an intuitive understanding, consider the extreme case
where the alternative features under study all have p-val-
ues equal to zero, whereas the null features have a uni-
form distribution over [0, 1]. Then F has probability mass
at p = 0 equal to the proportion of alternative features (1 -
π0), and in the interval (0, 1] is described by a straight line
between (0, 1 - π0) and (1, 1). It is clear that the best
threshold p0 is the one that selects all features with zero p-
values. This corresponds to the turning point of F-1 In
practice, the alternative features will not all have zero p-
values, but the turning point of F-1, where its second deriv-
ative is zero, remains the best threshold to yield a
compromise between false positives and false negatives
proportions.
Application to exponential distributions
To give some insight about how the proposed threshold
works, let us consider the case when the alternative p-val-
ues have an exponential distribution. This consists of one
of the simplest functional forms for a monotonically
decreasing density within [0, 1] with probability density
function given by
f1(p) = G(λ)e-λp, 0 ≤ p ≤ 1,   (3)
where  , a constant guaranteeing
that .  As  λ → 0, f1 approaches the uniform dis-
tribution. Equation (2) yields
If we replace this into (3), we obtain
and, by replacing the latter into expression (1) for f, we get
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Thus, the threshold is set at a point where the proportion
of the alternative features is half the proportion of the null
features. In other words, the genes with a p-value less than
this threshold all have some evidence against the null
hypothesis, whereas very few truly differentially expressed
genes are excluded. For many purposes this definition
gives a too wide selection, and it is more desirable to have
a point where the proportion of alternative genes is higher
than the proportion of null genes, e.g. at a point p1 where
. At p1, the proportion of alternative
genes is twice the proportion of null genes. However, with
the functional description given above, any point depend-
ing on the ratio between the proportions of null and alter-
native genes can be found in an unsupervised manner.
The dependency of the threshold p0 on λ and π0, is visual-
ized in figure 5. In this figure, it is clear that the suggested
threshold p0 varies with π0 and λ in the desired way: as λ
increases, the separation between the null and alternative
p-values distributions increases and, therefore, p0
decreases. On the other hand, as the proportion of null
genes π0 increases, naturally it becomes harder to identify
the alternative genes, and again p0 decreases.
For practical reasons it is desirable to have an estimate of
the proportion of false positives in the selection. Provided
the described functions, we can integrate f0 and f in the
interval [0, max(p)]. The ratio between the two will be an
estimate of the proportion of false positives.
Extensions to more than one alternative component are
straightforward and given in appendix. Application of the
more flexible beta distribution yield comparable results
(see appendix).
The p-value threshold dependencies on π0 and λ Figure 5
The p-value threshold dependencies on π0 and λ. p-values come from a mixture of π0 null genes and a single population 
of 1 - π0 alternative genes following an exponential distribution   visualized in (A) a 3D plot and (B) a 
contour plot of p0.
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Non-parametric approach
In practice, there is interest in making as few distribu-
tional assumptions as possible so as to yield a robust
approach. We suggest estimating F  non-parametrically.
This can be done by plotting the sorted p-values of all
genes against their percentile rank (as the scatterplots in
figures 1B and 1D) and estimating F-1 by fitting a smooth
function – such as a cubic spline – to the data points. The
smoothing parameters are chosen by cross-validation.
In non-parametric regression, the equivalent degrees of
freedom for noise (EDF) is defined by EDF = tr{I - A(α)},
where  A(α) is the hat matrix associated with spline
smoothing with smoothing parameter α. The relation
between  EDF, the generalized cross validation (GCV)
score and the residual sum of squares [15,16] can be writ-
ten as
The optimal EDF, and thus smoothing parameter, to fit
the smoothing spline is found by minimizing the residual
sum of squares.
To get the curvature of the spline,  , it is differentiated
numerically twice. The critical points p0, of this second
derivative can be identified.
The R code and additional information is available at
http://www.medgencentre.nl/pla.
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